-
With elections ahead, Latvia's Russian-speakers reject Moscow's help
-
North Korea denies South's claim it was apparently behind DMZ mine blasts
-
Brazil football clubs face massive sponsorship blow from betting ban
-
West Bank's violent settlers part of a new generation fuelled by ideology
-
ChatGPT maker wants to be the App Store for AI as safety concerns grow
-
US-led coalition ends mission in Iraq
-
Women fight fires and sexism in Indonesian Borneo
-
Pope-backed White Sox join Braves with MLB playoff wins
-
Forsling's OT blast lifts Florida over Carolina in NHL opener
-
NBA close to picking new $12-13bn Vegas team owners: report
-
Hurricane Polo sweeps over Mexico's Pacific coast, heads inland
-
LA28 Olympics torch relay to visit all 50 states
-
Grynspan pulls ahead in race to lead UN: diplomat
-
Spain brush aside Croatia in Nations League, England down Czechs
-
Trump touts AI boss pledge to self-regulate
-
Trump hails 'morally binding' AI self-regulation pledge
-
Oil down, but stocks lower as bond yields rise
-
Yamal inspires Spain to Croatia romp on World Cup homecoming
-
England break down stubborn Czechs to claim first Nations League win
-
UN to hold fourth informal poll of secretary-general candidates
-
UN Security Council extends Haiti anti-gang force by 6 months
-
Who are the Emiratis behind crisis-hit Manchester City?
-
Manchester City guilty of Premier League charges: What comes next?
-
Singer Angelique Kidjo urges Africans to 'create together'
-
Man City chief Soriano slams Premier League 'conspiracy theory'
-
Alleged Rihanna mansion shooter mentally fit for trial, says judge
-
Hurricane Polo sweeps over Mexico's Pacific coast
-
Mystery over UK airbase scare as police find petrol not explosives
-
Man City must be relegated after guilty verdict says club's former chairman
-
OpenAI unveils low-cost AI model, a day after shelving Astra upgrade
-
German far-right aims to lead Saxony-Anhalt govt in December
-
Premier League confirms Man City guilty of serious financial breaches
-
Little damage as Hurricane Polo sweeps over Mexico's Pacific coast
-
Brazil's Lula turns to Bad Bunny tune to criticise Trump ahead of polls
-
Manchester City guilty of breaking financial rules - Premier League
-
Nigerian dancer eyes world record after seven-day marathon
-
FIFA boss Infantino blasted as would-be 'emperor' by UEFA's Ceferin
-
Swiss regulator concludes Julius Baer bank probe
-
Stocks move lower despite oil prices dropping
-
Brazil's patron saint pulled into latest election scrap
-
AI driving up innovation investment: UN
-
Football overload leaves players near 'breaking point', warns Tebas
-
UN Security Council extends Haiti mission by 6 months
-
Paris Eiffel Tower says chief to step down after uproar over removing women staff
-
Man Utd do not deserve medals if Man City stripped of titles: Rooney
-
Amaze Holdings (NYSE: AMZE) Executes Binding LOI to Acquire BullionFX | Alchemy, a Decentralized Gold-Backed Financial Ecosystem for Valued at US$155 Million
-
Vana Completes Expanded Staking as Part of the Vega Upgrade, Publishes Expanded VANA Token Economics
-
Clashes between French teens, police as school blockades intensify
-
Spain to cap gas price hikes, extend fuel discounts
-
Stocks move sideways despite oil moving lower
US greenlights pig kidney transplant trials
Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.
United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.
Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.
United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.
The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.
The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.
Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.
"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.
Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.
Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.
Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.
United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.
Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.
She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.
W.Morales--AT